Research Article | Open Access
Amoebicidal Activity of Essential Oil of Dysphania ambrosioides (L.) Mosyakin & Clemants in an Amoebic Liver Abscess Hamster Model
Amebiasis is a parasitic disease that extends worldwide and is a public health problem in developing countries. Metronidazole is the drug recommended in the treatment of amebiasis, but its contralateral effects and lack of continuity of treatment induce low efficiency, coupled with the appearance of resistant amoebic strains. Therefore, the search of new compounds with amoebicidal activity is urgent and important. In this study, we evaluated the in vitro and in vivo antiamoebic activity of the essential oil Dysphania ambrosioides (L.) Mosyakin & Clemants. It exhibited an IC50 = 0.7 mg/mL against trophozoites. The oral administration of essential oil (8 mg/kg and 80 mg/kg) to hamster infected with Entamoeba histolytica reverted the infection. Ascaridole was identified as the main component of essential oil of D. ambrosioides. The identification of amoebicidal activity of Ascaridole gives support to the traditional use. Further studies with Ascaridole will be carried out to understand the mechanism involved.
Amebiasis is the infection of human gastrointestinal tract caused by Entamoeba histolytica, a protozoan parasite capable of invading the intestinal mucosa and that may spread to other organs, mainly the liver which usually leads to amoebic liver abscess. Spread occurs via the fecal-oral route, generally, by poor hygiene during food preparation and eating or by the use of human waste as fertilized crops. Crowding and poor hygiene contribute to its prevalence in Africa, Asia, and Latin America. Fifty millions of people suffer from amebic colitis y/o liver abscess caused by Entamoeba histolytica resulting in 50,000 to 100,000 deaths yearly . For example, it was observed that 39% of children from an urban slum in Dhaka, Bangladesh, had a new E. histolytica infection during 1-year study. This infection remains a significant cause of morbility worldwide . Among children, under 5 years who were admitted with acute diarrhea in a hospital, Entamoeba histolytica was confirmed in 7.8% of the cases . The estimated number of infected cases may be much higher due to asymptomatic diseases and lack of a sensitive and specific diagnostic test .
Metronidazole is commonly used and recommended as the treatment of amebiasis . However, it is less effective in the tissue than in the gut lumen . In addition, it can eradicate only up to 50% of laminae infections, and this drug has been reported to have unpleasant side effects such as metallic taste, headache, dry mouth, and to a lesser extent nausea, urticaria, pruritus, and dark-colored urine [7–9]. Thus, the search for alternative antiamebic compounds with high activity, cheap, and more effective is still a necessary goal.
Dysphania ambrosioides (L.) Mosyakin & Clemants before known as Chenopodium ambrosioides traditionally named “Epazote” is a herb native to South America. It is also cultivated in subtropical and subtemperate regions, mostly for consumption as leafy vegetable and herb. Because of the pungent flavor, it is traditionally used to flavor beans and other South American dishes [10, 11]. Herb is a plant widely known in popular medicine as anthelmintic, vermifuge, and emmenagogue [10, 12]. It is used in the treatment of digestive, respiratory, urogenital, vascular, and nervous disorders. Kumar et al.  described the antifungal activities of Chenopodium oil against eight fungi including: Aspergillus niger, Aspergillus fumigatus, Botryodiplodia theobromae, Fusarium oxysporum, Sclerotium rolfsii, Macrophomina phaseolina, Cladosporium cladosporioides and Helmintosporium oryzae [10, 13]. Ascaridole is the main active compound found in the essential oil [14–16]. It was found to be a potent inhibitor in vitro development of Plasmodium falciparum, Trypanosoma cruzi, and Leishmania amazonensis . Chenopodium ambrosioides continues to be used widely to treat intestinal disorders and other illness in humans, with apparent success . Although that chemical composition of Epazote is known, amoebicidal properties have not been linked to specific essential oil. In this study, we report the amoebicidal activity of Mexican Epazote against Entamoeba histolytica, by assessing its effect in vitro and in vivo on the model of amebic liver Abscess induced in the hamster .
2. Material and Methods
2.1. Plant Material
Epazote leaves were bought from a local market (“Central Comercial Agropecuario,” Aguascalientes, Lat 21.91117, Long 102.28984). A voucher specimen (number 7607, Ph.D. Maria Elena Siqueiros Delgado) was deposited at the botanical garden at Autonomous University of Aguascalientes. The dried plant material was grounded and mixed 1 : 5 with water and subjected to stream distillation for 3 hours at the atmospheric pressure. The distillate was extracted twice with dichloromethane (1 : 1 v/v). The organic phase was collected and dried with anhydrous sodium sulfate; dichloromethane was evaporated in a rotator evaporator at 30°C under reduced pressure and weighted. The hydrodistillation of the plant yielded clear oil with characteristic odor.
Animals. Golden male hamsters (Mesocricetus auratus) from six to eight weeks old (weight 100–160) were maintained in cycles of light/dark (12 : 12); food was supplied from Ralston Rations-Kansas (Purina) and water ad libitum in the animal facility of the Autonomous University of Aguascalientes. The animal use protocol that was approved by the Ethics Committee of the Autonomous University of Aguascalientes.
2.2. Essential Oil Analysis
The compounds in the essential oil of Epazote were tentatively identified by gas chromatography combined with mass spectrometry (GC-MS). Mass spectral data were obtained on a gas chromatograph-mass spectrometer (Agilent GC model 6850, Agilent MS model 5975C). Fused capillary columns HP5-MS (; film thickness of 0.25 m). The GC oven temperature was programmed from 60 to 200°C with increments 15°C/min. One microliter of the sample was injected by the split mode (10 : 1) with the split vent being closed for 30 s. Helium was the carrier gas at flow of 2 mL/min. The mass spectrometer was scanned from m/z 30 to 500 UM in electron impact mode (70 eV), and chromatogram time was 10 min. The identification of individual components was based on their spectral fragmentation according to the mass spectra library Wiley, retention indices, and comparison with published data. It only compounds with similarity indexes of 90% that were considered as positive identifications.
2.3. Entamoeba histolytica Culture
Entamoeba histolytica HM-1 : IMSS strain was used for all experiments; the trophozoites were cultured axenically in screw-cupped tubes at 35.5°C on Diamond’s TYI-S-33 medium, supplemented with 10% (v/v) heat-inactivated bovine serum. Subcultures were performed routinely at 48 hr intervals by replacing the medium without detaching the monolayer. Cells were harvested by replacing the medium with fresh one, chilling on ice for 20 min, and inverting gently to detach the monolayer.
2.4. Measurement of Amoebic Activity In Vitro
The Epazote essential oil (EEO) was sterilized through a 0.22 m Millipore filter and then transferred to sterile Eppendorf tube. Different concentrations of essential oil (0.05, 0.1, 0.25, 0.5, 0.75, 1.0, 1.25, and 1.5 mg/mL) and metronidazole (10 g/mL as standard amoebicidal) were prepared in test tubes by serial dilutions in sterile water. Diamond’s TYI-S-33 medium was added to the test tubes. Subsequently, trophozoites of Entamoeba histolytica were added to the test tubes and then incubated at 36°C for 48 h. After this time, the tubes were chilled for 20 min, and 1 mL of the medium was taken off from each tube for the viability count using trypan blue exclusion technique. Motility and dye exclusion were the criteria for viability. The percentage of growth inhibition was calculated using the following formula: % GI = . The experiments were performed in triplicate and repeated three times.
2.5. Measurement of Amoebic Activity In Vivo
Twenty-five male golden hamsters (Mesocricetus auratus) were divided into five groups of five animals each. First, group was considered as intact control, and other groups were inoculated with 30–40 × 104 trophozoites in the central hepatic lobe to induce amoebic liver abscess (ALA) [19, 20]. Second group was called positive control, the third and fourth groups were treated with EEO to 8 mg/kg and 80 mg/kg, the fifth group was treated with metronidazole 0.1 mg/kg daily administered orally for 7 days after inoculation of amebas, and then hamsters were sacrificed. Livers were dissected and weighted, and representative tissue samples were fixed in 10% neutral formalin. Tissue liver slides were stained with haematoxylin-eosin and Masson trichrome methods . The identification of trophozoites in amoebic liver abscesses was carried out by antibody versus Lectin 220 Kd (Kindly donated by Dr. Talamás-Rohana).
2.6. Statistical Analysis
The values were expressed as average ±S.D. The results were analyzed by Analysis of Variance (ANOVA) followed by the Tukey’s test. The analyses were performed with the software GraphPad Prism 5.0.4. Differences were considered significant at . The IC50 estimation was evaluated using the logistic-curve model with GraphPad Prism 5.0.4 software.
3. Results and Discussion
Hydrodistillation of the Epazote plant yielded 1.0% essential oil on a fresh weight basis. Through GC-MS and chemical analysis, a total of 5 components were identified in essential oil, accounting for 93.2% of this total oil. The main constituents of the essential oil were Ascaridole epoxide (45.5%), cis-Ascaridole (34.2%), 7-oxabyciclo(4.1.0) Heptan 2-one, 3 methyl-6-(1-methy-ethyl) (2.5%), 2-propenoic acid, 2-methyl, dodecyl ester (7.2%), and Methacrylic acid, tetradecyl ester (3.54%) (Figure 1). The cis-Ascaridole and Ascaridole epoxide account at the 79% of essential oil. The results of the chemical composition of essential oil of Dysphania are in the category of rich oils in ascaridole  and it is agreed to the study published by Jardim et al. . The chemical characterization of the essential oil of the 13 species medicinal in the genus Chenopodium, too, identified cis-Ascaridole as a major compound with range from 4.2% to 46.9% [15, 23]. Ascaridole epoxide has been described as a metabolite in the synthesis pathway of Ascaridole. Dembitsky et al.  mentioned that the sum of Ascaridole-related compounds is a more accurate quantitative, and the total content can be obtained by GC-MS analysis.
The EEO amebicidal ability was assayed using trypan blue exclusion; the viable trophozoites of Entamoeba histolytica remained clear in the control, whereas trophozoites exposed to metronidazole or EEO were light blue in color. Incubation of Entamoeba histolytica trophozoites in the range 0–1.25 mg/mL of essential oil caused growth inhibition, many trophozoites were observed suspended within the tube after incubation time, and they showed spherical form and amorphous mass without amoebic movement (Figures 2(b) and 2(c)). When the concentration range increased, the number of living trophozoites decreased (Figure 2(a)). The EEO showed an IC50 of 0.75 mg/mL; from this result, two doses of 10 and 100 higher than IC50 were choice for testing the antiprotozoal activity by an in vivo study. Essential oil from Epazote had amoebicidal activity dose-dependent. Although, some medicinal plants have been found with antiamoebic effect in vitro, there are a few data about the Epazote related to Entamoeba histolytica; thus, Calzada et al.  have reported that methanolic extract of Chenopodium ambrosioides showed a moderate activity toward Entamoeba histolytica. In the same way, other plants have been antiamoebic activity, including Codiaeum variegatum , Thymus vulgaris , and Chiranthodendron pentadactylon . The essential oil of genus Chenopodium has displayed great activity against intracellular parasites, including Trypanosoma cruzi, Plasmodium falciparum, and Leishmania amazonensis [17, 27, 28].
Most plant studies have been addressed to test the amoebicidal activity in vitro [24–26]; however, few studies, if any, have been done to examine the amoebicidal effects of Epazote in vivo amoebic liver abscess. Seven days after Entamoeba histolytica inoculation, there was a significance difference in liver weights in three experimental groups: ALA, EEO 8 mg + ALA, and EEO 80 mg + ALA (4.67 ± 0.42 g, 0.17 ± 0.5, and 0.04 ± 0.05 g, , resp., Figure 3). The animals inoculated with Entamoeba histolytica developed abscesses as well as the presence of multiple granulomas (Figure 4(b)). However, hamsters treated with essential oil of Epazote 8 mg daily after amebic inoculation had developed smaller abscesses, and two hamsters treated with 80 mg developed abscesses. In contrast, only one animal treated with metronidazole showed ALA. The quantity of amoebas in area of the abscess was estimated by immunohistochemistry with an antibody for ameba Lectin 220 kDa. Hamsters inoculated with Entamoeba histolytica had 9.8 ± 2 amebas/mm2. Hamsters treated with 8 mg of EEO was not different from control (11.1 ± 3.4 amebas/mm2); however, animals treated with EEO 80 mg was significant versus control (3.5 ± 2.1 amebas/mm2, , ). In addition, liver immunohistochemistry for 220 KDa in animals infected showed fragmented amebas in the granuloma area with fibrosis and inflammatory infiltrate. In contrast, animals with ALA treated with a low dose of EEO showed minor inflammatory infiltrate with trophozoites around hepatic sinusoid (Figure 5(b)). Whereas, animals treated with high dose of EEO had a scarce inflammatory infiltrate and less fibrosis (Figure 5(d)) compared to animals with ALA (Figure 5(b)). Therefore, the Ascaridole had an amebostatic effect that suggests a total reversion.
Some studies have reported that the administration of Epazote infusions or EEO can be lead to overdoses [11, 14]. However, the administration by oral route for seven days in this study showed to be safe, because there are no deaths among the animals. The result is in agreement with others that administrated EEO for oral route and long periods [17, 29]. On the other hand, Ascaridole partial effectiveness found in groups with ALA + EEO could be due to its pharmacokinetics because Ascaridole has been shown to have a half-life of 0.5 h, when administered orally (doses 30, 60, and 120 mg/kg) and it is removed rapidly from the blood stream .
The complete cure of the animals treated with the essential oil of Epazote did not occur totally. However, untreated animals develop the inexorable disease; the hamsters treated with the essential oil by oral route had small lesions and low parasite burden (Figures 3 and 5). The model of ALA due to Entamoeba histolytica is not a perfect model, because it is a highly virulent strain and causes a disseminating, ‘‘noncure,’’ and it carries on fatal diseases in hamsters. However, the efficacy partial to EEO produces a consistent protection against the Entamoeba histolytica.
Our results show that EEO has antiamoebic activity in vitro and in vivo. Since, the Ascaridole was detected by CG-MS as the major component of Epazote, we suppose that antiamoebic effect could be due to 1, 4 endoperoxide which has been found as the active component for anthelmintic and antimalarial effects [14, 27]. It is interesting to speculate about the mechanism by which Ascaridole kills trophozoites. It is an endoperoxide that it can deliver reactive oxygen species and damage the trophozoites in a similar way that oxygen peroxide induces toxicity to amoeba . Recently, Monzote et al.  reported the toxic effects of Chenopodium essential oil and its components on some protozoa as Leishmania, Trypanosoma brucei, and Trypanosoma cruzi, and they concluded that the Ascaridole exhibited the better antileishmanial activity and suggest that the action mechanism through the generation of oxygen radicals, mitochondrial dysfunction, and a modification of redox indexes. This mechanism might not be applicable to amoebas, because they have not mitochondria; however, the free radical can be impact on their membrane electron transport system that serves to maintain in good condition the redox balance . Alternatively, other targets of Ascaridole in the amoeba can be free radical-triggered DNA or protein alterations.
In this study, we have described the ostentation of EEO from Epazote. The Ascaridole is the main component of the essential oil. It exhibited antiamoebic activity in vitro and in vivo against Entamoeba histolytica. This report provides important information on biologically active terpenoid compounds found in traditional medicine plants as the Epazote.
Conflict of Interests
All the authors declare that they have not any conflict of interests.
The authors appreciate the support given by Ph.D. Maria Elena Siqueiros Delgado in the classification and identification of the Dysphania ambrosioides plant. This work was supported by the National Council of Science and Technology (CONACYT-103679) and the Autonomous University of Aguascalientes, México (PIBB07-6N).
- M. Tanyuksel and W. A. Petri Jr., “Laboratory diagnosis of amebiasis,” Clinical Microbiology Reviews, vol. 16, no. 4, pp. 713–729, 2003.
- S. L. Stanley Jr. and S. L. Reed, “Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 280, no. 6, pp. G1049–G1054, 2001.
- O. Suwatano, “Acute Diarrhea in under five-year-old children admitted to King Mongkut Prachomklao hospital, phetchaburi province,” Journal of the Medical Association of Thailand, vol. 80, no. 1, pp. 26–32, 1997.
- W. A. Petri Jr. and U. Singh, “Diagnosis and management of amebiasis,” Clinical Infectious Diseases, vol. 29, no. 5, pp. 1117–1125, 1999.
- S. M. Townson, P. F. L. Boreham, P. Upcroft, and J. A. Upcroft, “Resistance to the nitroheterocyclic drugs,” Acta Tropica, vol. 56, no. 2-3, pp. 173–194, 1994.
- K. K. Bhopale, K. S. Pradhan, K. B. Masani, and C. L. Kaul, “Additive effect of diloxanide furoate and metronidazole (Entamizole R) in experimental mouse caecal amoebiasis,” Indian Journal of Experimental Biology, vol. 33, no. 1, pp. 73–74, 1995.
- T. B. Gardner and D. R. Hill, “Treatment of giardiasis,” Clinical Microbiology Reviews, vol. 14, no. 1, pp. 114–128, 2001.
- J. A. Upcroft, R. W. Campbell, K. Benakli, P. Upcroft, and P. Vanelle, “Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and- resistant Giardia, Trichomonas, and Entamoeba spp,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 1, pp. 73–76, 1999.
- P. Upcroft and J. A. Upcroft, “Drug targets and mechanisms of resistance in the anaerobic protozoa,” Clinical Microbiology Reviews, vol. 14, no. 1, pp. 150–164, 2001.
- C. M. Jardim, G. N. Jham, O. D. Dhingra, and M. M. Freire, “Composition and antifungal activity of the essential oil of the brazilian Chenopodium ambrosioides L,” Journal of Chemical Ecology, vol. 34, no. 9, pp. 1213–1218, 2008.
- W. S. Pereira, B. P. Ribeiro, A. I. P. Sousa et al., “Evaluation of the subchronic toxicity of oral treatment with Chenopodium ambrosioides in mice,” Journal of Ethnopharmacology, vol. 127, no. 3, pp. 602–605, 2010.
- A. Jabbar, M. A. Zaman, Z. Iqbal, M. Yaseen, and A. Shamim, “Anthelmintic activity of Chenopodium album (L.) and Caesalpinia crista (L.) against trichostrongylid nematodes of sheep,” Journal of Ethnopharmacology, vol. 114, no. 1, pp. 86–91, 2007.
- R. Kumar, A. K. Mishra, N. K. Dubey, and Y. B. Tripathi, “Evaluation of Chenopodium ambrosioides oil as a potential source of antifungal, antiaflatoxigenic and antioxidant activity,” International Journal of Food Microbiology, vol. 115, no. 2, pp. 159–164, 2007.
- D. MacDonald, K. VanCrey, P. Harrison et al., “Ascaridole-less infusions of Chenopodium ambrosioides contain a nematocide(s) that is(are) not toxic to mammalian smooth muscle,” Journal of Ethnopharmacology, vol. 92, no. 2-3, pp. 215–221, 2004.
- V. Dembitsky, I. Shkrob, and L. O. Hanus, “Ascaridole and related peroxides from the genus Chenopodium,” Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 152, no. 2, pp. 209–215, 2008.
- Y. Chu, W. Li, J. Han et al., “Determination and pharmacokinetics of ascaridole in rat plasma by gas chromatography-mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 3, pp. 997–1000, 2008.
- L. Monzote, A. M. Montalvo, R. Scull, M. Miranda, and J. Abreu, “Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: A preliminary study,” Biomedicine and Pharmacotherapy, vol. 61, no. 2-3, pp. 148–153, 2007.
- M. B. Quinlan, R. J. Quinlan, and J. M. Nolan, “Ethnophysiology and herbal treatments of intestinal worms in Dominica, West Indies,” Journal of Ethnopharmacology, vol. 80, no. 1, pp. 75–83, 2002.
- V. Tsutsumi, R. Mena-Lopez, F. Anaya-Velazquez, and A. Martinez-Palomo, “Cellular bases of experimental amebic liver abscess formation,” American Journal of Pathology, vol. 117, no. 1, pp. 81–91, 1984.
- M. Muñoz-Ortega, A. Quintanar-Stephano, M. García Lorenzana et al., “Modulation of amoebic hepatic abscess by the parasympathetic system,” Parasite Immunology, vol. 33, no. 1, pp. 65–72, 2011.
- L. G. Luna, Manual of Histologic Staining Methods. Institute of Pathology, Armed Forces, McGraw-Hill, New York, NY, USA, 3rd edition, 1968.
- Q. B. Chuan, L. L. Zhi, and Z. L. Qi, “Nematicidal constituents from the essential oil of Chenopodium Ambrosioides aerial parts,” E-Journal of Chemistry, vol. 8, no. 1, pp. S143–S148, 2011.
- H. P. Singh, D. R. Batish, R. K. Kohli, S. Mittal, and S. Yadav, “Chemical composition of essential oil from leaves of Chenopodium ambrosioides from Chandigarh, India,” Chemistry of Natural Compounds, vol. 44, no. 3, pp. 378–379, 2008.
- F. Calzada, L. Yépez-Mulia, and A. Aguilar, “In vitro susceptibility of Entamoeba histolytica and Giardia lamblia to plants used in Mexican traditional medicine for the treatment of gastrointestinal disorders,” Journal of Ethnopharmacology, vol. 108, no. 3, pp. 367–370, 2006.
- P. F. Moundipa, K. G. M. Flore, C. F. B. Bilong, and I. Bruchhaus, “In vitro amoebicidal activity of some medicinal plants of the Bamun region (Camerron),” African Journal of Traditional Complementary Alternative Medicine, vol. 2, pp. 113–121, 2005.
- M. Behnia, A. Haghighi, H. Komeylizadeh, S.-J. S. Tabaei, and A. Abadi, “Inhibitory effects of Iranian Thymus vulgaris extracts on in vitro growth of Entamoeba histolytica,” Korean Journal of Parasitology, vol. 46, no. 3, pp. 153–156, 2008.
- F. Kiuchi, Y. Itano, N. Uchiyama et al., “Monoterpene hydroperoxides with trypanocidal activity from Chenopodium ambrosioides,” Journal of Natural Products, vol. 65, no. 4, pp. 509–512, 2002.
- Y. Pollack, R. Segal, and J. Golenser, “The effect of ascaridole on the in vitro development of Plasmodium falciparum,” Parasitology Research, vol. 76, no. 7, pp. 570–572, 1990.
- L. TrivellatoGrassi, A. Malheiros, C. Meyre-Silva et al., “From popular use to Pharmacological validation: a study of the anti-inflammatory anti-nociceptive and healing effects of Chenopodium ambrosoides extract,” Journal of Etnopharmacology, vol. 145, pp. 127–138, 2013.
- A. Olivos, E. Ramos, M. Nequiz et al., “Entamoeba histolytica: mechanism of decrease of virulence of axenic cultures maintained for prolonged periods,” Experimental Parasitology, vol. 110, no. 3, pp. 309–312, 2005.
- L. Monzote, M. Garcia, J. Pastor et al., “Essential oil from Chenopodium ambrosoides and main components: activity against Leishmania, their mitochondria and other microorganisms,” Experimental Parasitology, vol. 136, pp. 20–26, 2014.
- T. Bera, N. Nandi, D. Sudhahar, M. A. Akbar, A. Sen, and P. Das, “Preliminary evidence on existence of transplasma membrane electron transport in Entamoeba histolytica trophozoites: a key mechanism for maintaining optimal redox balance,” Journal of Bioenergetics and Biomembranes, vol. 38, no. 5-6, pp. 299–308, 2006.
Copyright © 2014 Manuel Enrique Ávila-Blanco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.